Cencora Inc (COR)

NYSE
Currency in USD
293.13
-0.53(-0.18%)
Closed·
After Hours
293.130.00(0.00%)
·
COR Scorecard
Full Analysis
Management has been aggressively buying back shares
COR is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
290.87297.29
52 wk Range
218.65309.35
Key Statistics
Edit
Prev. Close
293.66
Open
295.79
Day's Range
290.87-297.29
52 wk Range
218.65-309.35
Volume
1.51M
Average Volume (3m)
1.73M
1-Year Change
23.85%
Book Value / Share
5.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
COR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
321.50
Upside
+9.68%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 20 consecutive years

Cencora Inc News & Analysis

Show more

Cencora Inc Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Cencora Inc SWOT Analysis


Specialty Powerhouse
Cencora's dominance in specialty pharmaceuticals drives growth, with strategic acquisitions like RCA expanding its footprint in high-value markets
Financial Resilience
Strong Q3 results and raised FY24 guidance showcase Cencora's robust performance, with 24 years of consistent dividends and 20 years of growth
Market Dynamics
Explore how Cencora navigates industry trends, including the impact of GLP-1 drugs and post-pandemic market normalization on its growth trajectory
Future Prospects
Analyst targets range from $263 to $290, reflecting optimism about Cencora's potential in the evolving healthcare distribution landscape
Read full SWOT analysis

Cencora Inc Earnings Call Summary for Q2/2025

  • Cencora beats Q1 2025 expectations with EPS of $4.42 and revenue of $75.5B, stock surges 5.14% to $305.77
  • Strong performance in US Healthcare Solutions segment drives 10% revenue growth and 16% adjusted diluted EPS increase
  • Full-year EPS guidance raised to $15.70-$15.95, with 8-10% consolidated revenue growth expected
  • Company focuses on specialty medications and international expansion, anticipates rebound in clinical trial demand
  • Cencora maintains 25-year dividend streak, trades near fair value with low volatility (beta 0.6)
Last Updated: 2025-05-07, 09:54 a/m
Read Full Transcript

Compare COR to Peers and Sector

Metrics to compare
COR
Peers
Sector
Relationship
P/E Ratio
33.6x15.8x−0.5x
PEG Ratio
−5.63−0.080.00
Price/Book
56.1x5.6x2.6x
Price / LTM Sales
0.2x2.7x3.0x
Upside (Analyst Target)
11.5%8.1%52.5%
Fair Value Upside
Unlock−0.7%8.7%Unlock

Analyst Ratings

11 Buy
5 Hold
1 Sell
Ratings:
17 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 321.50
(+9.68% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.66%
Dividend Yield
0.75%
Industry Median 0.75%
Annualized payout
2.20
Paid quarterly
5-Years Growth
+5.53%
Growth Streak

Earnings

Latest Release
May 07, 2025
EPS / Forecast
4.42 / 4.06
Revenue / Forecast
75.50B / 75.14B
EPS Revisions
Last 90 days

COR Income Statement

People Also Watch

161.07
KEYS
+1.07%
105.66
CRUS
+1.27%
163.99
CAH
+0.36%
26.29
YOU
+4.57%
53.40
CNC
-1.84%

FAQ

What Is the Cencora Inc (COR) Stock Price Today?

The Cencora Inc stock price today is 293.13

What Stock Exchange Does Cencora Inc Trade On?

Cencora Inc is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Cencora Inc?

The stock symbol for Cencora Inc is "COR."

Does Cencora Inc Pay Dividends? What’s The Current Dividend Yield?

The Cencora Inc dividend yield is 0.75%.

What Is the Cencora Inc Market Cap?

As of today, Cencora Inc market cap is 56.82B.

What Is Cencora Inc's Earnings Per Share (TTM)?

The Cencora Inc EPS (TTM) is 8.66.

When Is the Next Cencora Inc Earnings Date?

Cencora Inc will release its next earnings report on Jul 30, 2025.

From a Technical Analysis Perspective, Is COR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Cencora Inc Stock Split?

Cencora Inc has split 3 times.

How Many Employees Does Cencora Inc Have?

Cencora Inc has 44000 employees.

What is the current trading status of Cencora Inc (COR)?

As of Jun 24, 2025, Cencora Inc (COR) is trading at a price of 293.13, with a previous close of 293.66. The stock has fluctuated within a day range of 290.87 to 297.29, while its 52-week range spans from 218.65 to 309.35.

What Is Cencora Inc (COR) Price Target According to Analysts?

The average 12-month price target for Cencora Inc is USD321.49667, with a high estimate of USD355 and a low estimate of USD257.45. 11 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +9.68% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.